Here, using a poorly immunogenic LLC lung carcinoma model, we examined the activation status and diversity distribution of tumor-infiltrating T cells after intratumoral treatment with a series of recombinant oncolytic vaccinia viruses carrying transgenes to express IL-7, IL-12 or both, and investigated the association with antitumor efficacy. The gene discussed is IL7; the disease is neoplasm.